Nucleome Therapeutics Ltd invites a Principal Scientist to lead translational bioanalysis and biomarker strategies for our autoimmune antibody programme. You will guide PK, ADA, PD and exploratory biomarker plans across discovery, preclinical and IND-enabling studies.
You will partner with cross-functional teams to drive translational dose selection, manage CROs, and set up biomarker labs for future clinical work and IND filings.
Principal Scientist, Translational Bioanalysis & Biomarkers in Oxford employer: Nucleome Therapeutics Ltd
Nucleome Therapeutics is an exceptional employer, offering a dynamic work environment that fosters innovation and collaboration in the field of biotechnology. As a Principal Scientist, you will have the opportunity to lead cutting-edge biomarker strategies while working alongside a passionate team dedicated to advancing transformative therapies. With a strong emphasis on employee growth, Nucleome provides ample opportunities for professional development and the chance to make a meaningful impact in the fight against autoimmune diseases.
